Premium
OUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA
Author(s) -
Gac A.,
Chartier L.,
Girinsky T.,
Gotti M.,
Lazarovici J.,
Aurer I.,
Musto P.,
Damaj G.,
Federico M.,
Fortpied C.,
Raemaekers J.,
Meignan M.,
Hutchings M.,
Versati A.,
Andre M.,
Reman O.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.104_2630
Subject(s) - medicine , salvage therapy , radiation therapy , randomization , chemotherapy , regimen , randomized controlled trial , surgery , stage (stratigraphy) , paleontology , biology